The association between normal capillary refill time and 28-day mortality in septic shock patients subjected to early hemodynamic resuscitation

PURPOSE: Capillary refill time (CRT)-guided resuscitation improves outcomes in septic shock by targeting abnormal CRT. However, whether a normal baseline CRT, resulting in no additional attempts to optimize hemodynamics, is associated with mortality remains unclear. We evaluated the association between normal baseline CRT and 28-day mortality in patients with septic shock undergoing protocolized resuscitation. METHODS: This post-hoc analysis included all randomized patients from the ANDROMEDA-SHOCK 1 and 2 trials. CRT was classified as normal (≤3 s) or abnormal (>3 s). The primary outcome was 28-day mortality, analyzed using Cox proportional hazards regression and reported as hazard ratios (HR) with 95% confidence intervals (CI). Secondary outcomes included ICU and hospital length of stay and 90-day mortality. RESULTS: Among 1885 patients, 691 (36.7%) had normal baseline CRT. Despite normal CRT, many had abnormal hemodynamic features: 335 (48.5%) had heart rate > 100/min, 258 (37.3%) systolic arterial pressure < 100 mmHg, 152 (22.0%) mean arterial pressure < 65 mmHg, 157 (22.7%) diastolic arterial pressure < 50 mmHg, and 683 (98.8%) lactate >2 mmol/L. Patients with normal baseline CRT had significantly lower 28-day mortality than those with abnormal CRT (21.1% vs. 34.3%; HR 0.61, 95% CI 0.50-0.74; p < 0.001) similarly for 90-day mortality (25.9% versus 40.6%; HR 0.61, 95% CI 0.52-0.73; p < 0.001). CONCLUSION: In the ANDROMEDA-SHOCK trials, normal baseline CRT was associated with significantly lower 28- and 90-day mortality, although mortality remained still quite high. Further research should investigate how treatment of septic shock patients with normal CRT can be improved. TRIAL REGISTRATION: The ANDROMEDA-SHOCK 1 trial: ClinicalTrials.gov Identifier: NCT03078712 (study start at: 2017-03-01). The ANDROMEDA-SHOCK 2 trial: ClinicalTrials.gov Identifier: NCT05057611 (study start at: 2022-03-18).

Authors

Institutions

Publication Details

Journal
Journal of Critical Care
Published
2026-11-13
DOI
https://doi.org/10.1016/j.jcrc.2026.155827
Primary Topic
Sepsis Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

The association between normal capillary refill time and 28-day mortality in septic shock patients subjected to early hemodynamic resuscitation

Jan Bakker, Corstiaan A. den Uil, Jean–Louis Teboul, Marcela de Almeida Lopes et al.
2 links
Journal of Critical Care
Sepsis Diagnosis and Treatment
article

The association between normal capillary refill time and 28-day mortality in septic shock patients subjected to early hemodynamic resuscitation

Jan Bakker, Corstiaan A. den Uil, Jean–Louis Teboul, Marcela de Almeida Lopes, Glenn Hernández P, Gustavo Adolfo Ospina-Tascón, Wim J. R. Rietdijk, Eduardo Kattan, Daniel De Backer
article en

Abstract

PURPOSE: Capillary refill time (CRT)-guided resuscitation improves outcomes in septic shock by targeting abnormal CRT. However, whether a normal baseline CRT, resulting in no additional attempts to optimize hemodynamics, is associated with mortality remains unclear. We evaluated the association between normal baseline CRT and 28-day mortality in patients with septic shock undergoing protocolized resuscitation. METHODS: This post-hoc analysis included all randomized patients from the ANDROMEDA-SHOCK 1 and 2 trials. CRT was classified as normal (≤3 s) or abnormal (>3 s). The primary outcome was 28-day mortality, analyzed using Cox proportional hazards regression and reported as hazard ratios (HR) with 95% confidence intervals (CI). Secondary outcomes included ICU and hospital length of stay and 90-day mortality. RESULTS: Among 1885 patients, 691 (36.7%) had normal baseline CRT. Despite normal CRT, many had abnormal hemodynamic features: 335 (48.5%) had heart rate > 100/min, 258 (37.3%) systolic arterial pressure < 100 mmHg, 152 (22.0%) mean arterial pressure < 65 mmHg, 157 (22.7%) diastolic arterial pressure < 50 mmHg, and 683 (98.8%) lactate >2 mmol/L. Patients with normal baseline CRT had significantly lower 28-day mortality than those with abnormal CRT (21.1% vs. 34.3%; HR 0.61, 95% CI 0.50-0.74; p < 0.001) similarly for 90-day mortality (25.9% versus 40.6%; HR 0.61, 95% CI 0.52-0.73; p < 0.001). CONCLUSION: In the ANDROMEDA-SHOCK trials, normal baseline CRT was associated with significantly lower 28- and 90-day mortality, although mortality remained still quite high. Further research should investigate how treatment of septic shock patients with normal CRT can be improved. TRIAL REGISTRATION: The ANDROMEDA-SHOCK 1 trial: ClinicalTrials.gov Identifier: NCT03078712 (study start at: 2017-03-01). The ANDROMEDA-SHOCK 2 trial: ClinicalTrials.gov Identifier: NCT05057611 (study start at: 2022-03-18).

Journal of Critical CareVol. 97
Université Libre de Bruxelles (BE), Pontificia Universidad Católica de Chile (CL), Fordham University (US), Université Paris-Saclay (FR), Erasmus MC (NL), Fundación Valle del Lili (CO), Maasstad Ziekenhuis (NL), Centre Hospitalier Interrégional Edith Cavell (BE), Universidad Icesi (CO)
Good health and well-being
Sepsis Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon